The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|25|3775-3783

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3775-3783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab Combination Therapy: For the First-Line Treatment of Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 917-930

Adis International

Access to resources Recommend Favorite

Bevacizumab costly for ovarian cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 624, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Bevacizumab in Ovarian Cancer: Unanswered Questions

By Muggia Franco  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 931-936

Adis International

Access to resources Recommend Favorite

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

By Bose Chinmoy K  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 194-197

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition in Ovarian Cancer Progression: A Crucial Role for the Endothelin Axis

By  

Cells Tissues Organs, Vol. 185, Iss. 1-3, 2007-06 ,pp. : 85-94

Karger

Access to resources Recommend Favorite